Drugs that contain Lenvatinib Mesylate
1. List of Lenvima drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7253286 | EISAI INC | Nitrogen-containing aromatic derivatives |
Oct, 2025
(2 years from now) | |
| US7612208 | EISAI INC | Crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same |
Sep, 2026
(3 years from now) | |
| US11186547 | EISAI INC | High-purity quinoline derivative and method for manufacturing same |
Aug, 2035
(12 years from now) | |
| US10407393 | EISAI INC | High-purity quinoline derivative and method for manufacturing same |
Aug, 2035
(12 years from now) | |
| US10259791 | EISAI INC | High-purity quinoline derivative and method for manufacturing same |
Aug, 2035
(12 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9006256 | EISAI INC | Antitumor agent for thyroid cancer |
Jul, 2027
(4 years from now) | |
| US11090386 | EISAI INC | Method for suppressing bitterness of quinoline derivative |
Feb, 2036
(12 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity (ODE) | Aug 15, 2025 |
| M (M) | Dec 19, 2024 |
| New Indication (I) | Aug 10, 2024 |
Market Authorisation Date: 13 February, 2015
Treatment: Method for treating thyroid carcinoma including differentiated thyroid cancer; Treatment with lenvima by administering lenvima as a suspension
Dosage: CAPSULE;ORAL
LENVIMA family patents
17
Japan
16
United States
11
China
10
European Union
8
Korea, Republic of
7
Australia
5
Spain
4
Russia
4
Canada
4
Norway
4
Hungary
3
Austria
3
Denmark
3
Germany
3
Israel
3
Portugal
3
Taiwan
3
Mexico
2
Hong Kong
2
RS
2
Poland
2
Brazil
2
Singapore
2
New Zealand
2
Croatia
2
Cyprus
2
Jordan
2
South Africa
2
Lithuania
2
Slovenia
1
Malaysia
1
Argentina
1
ME
1
Belgium
1
Netherlands
1
Luxembourg
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic